Emcure Pharmaceuticals Limited — JV/Acquisition, 03-07-2026: Acquisition

Emcure's subsidiary, Marcan Pharmaceuticals, acquired all Class E Special Shares of Mantra Pharma Inc., a step-down subsidiary, for CAD 50 million (approx. 305 Cr). This move reinforces Emcure's full ownership and control over Mantra, which specializes in marketing and distributing prescription drugs and natural health products in Canada. The acquisition ensures a streamlined approach to Emcure's Canadian operations, leveraging Mantra's substantial annual turnover of CAD 96.67 million. This strategic consolidation strengthens Emcure's long-term footprint in the growing Canadian pharmaceutical market.